Profile data is unavailable for this security.
About the company
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
- Revenue in EUR (TTM)517.36m
- Net income in EUR47.62m
- Incorporated1967
- Employees2.81k
- LocationBoiron SA2 avenue de l ouest LyonnaisRONTALON 69510FranceFRA
- Phone+33 478456100
- Fax+33 478456291
- Websitehttps://www.boiron.fr/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Guerbet SA | 785.69m | 23.87m | 445.60m | 2.92k | 19.60 | 1.18 | 5.35 | 0.5671 | 1.80 | 1.80 | 62.15 | 29.97 | 0.7997 | 0.5983 | 5.80 | 269,071.90 | 2.26 | 1.40 | 2.96 | 1.86 | 78.01 | 76.02 | 2.82 | 1.82 | 1.21 | 5.62 | 0.5035 | 57.82 | 4.30 | -0.0993 | 158.05 | -12.61 | 5.23 | -10.07 |
Pharma Mar SA | 158.15m | 1.14m | 506.60m | 509.00 | 492.15 | 2.52 | 73.42 | 3.20 | 0.0561 | 0.0561 | 8.82 | 10.97 | 0.4311 | 0.2868 | 5.56 | 310,713.20 | 0.3099 | 18.52 | 0.4207 | 25.89 | 93.92 | 93.76 | 0.7189 | 28.87 | 2.22 | -- | 0.1842 | -- | -19.45 | 7.77 | -97.70 | -- | 46.37 | -- |
Gen Ilac ve Saglik Urnlr Snyi ve Tcrt AS | 233.91m | 13.04m | 510.05m | 622.00 | 39.10 | 3.67 | 24.75 | 2.18 | 1.52 | 1.52 | 27.17 | 16.12 | 1.16 | 6.53 | 7.72 | 13,105,500.00 | 6.45 | 12.39 | 8.91 | 17.53 | 22.07 | 19.06 | 5.55 | 6.95 | 0.9854 | -- | 0.2095 | -- | -23.38 | 47.18 | -28.97 | 147.97 | -- | -- |
Calliditas Therapeutics AB | 104.29m | -40.29m | 516.92m | 181.00 | -- | 16.09 | -- | 4.96 | -8.69 | -8.69 | 22.49 | 6.24 | 0.6332 | 5.02 | 8.77 | 6,667,895.00 | -24.46 | -26.46 | -30.27 | -30.27 | 94.99 | -- | -38.63 | -76.59 | 3.08 | -4.44 | 0.7427 | -- | 50.32 | -- | -13.08 | -- | -- | -- |
Valneva SE | 153.71m | -101.43m | 518.11m | 684.00 | -- | 4.03 | -- | 3.37 | -0.7343 | -0.7343 | 1.11 | 0.924 | 0.2843 | 2.54 | 4.69 | 224,726.60 | -18.76 | -15.39 | -31.44 | -25.06 | 34.37 | 35.94 | -65.99 | -34.95 | 1.37 | -3.57 | 0.6195 | -- | -57.46 | 6.34 | 29.21 | -- | 35.18 | -- |
Pharmanutra SpA | 100.20m | 12.83m | 521.80m | 105.00 | 40.39 | 9.53 | 34.67 | 5.21 | 1.33 | 1.33 | 10.41 | 5.66 | 0.9426 | 0.3648 | 4.90 | 954,304.80 | 12.07 | 18.39 | 16.12 | 24.80 | 97.56 | 96.36 | 12.81 | 17.77 | 1.83 | 57.61 | 0.3399 | 52.51 | 21.13 | 16.51 | -14.73 | 8.44 | 75.71 | 11.20 |
Philogen SpA | 23.13m | -6.16m | 533.68m | 160.00 | -- | 8.12 | -- | 23.07 | -0.1551 | -0.1551 | 0.5747 | 2.25 | 0.1887 | 6.65 | 7.95 | 144,562.50 | -5.03 | -7.32 | -5.56 | -8.36 | 40.04 | 32.04 | -26.64 | -58.66 | 6.84 | -- | 0.1414 | -- | -2.46 | 10.80 | -14.60 | -- | 51.78 | -- |
Basilea Pharmaceutica AG Allschwil | 161.54m | 10.71m | 553.82m | 147.00 | 47.06 | -- | 44.85 | 3.43 | 0.8765 | 0.8765 | 13.15 | -0.8335 | 0.7999 | 1.06 | 5.16 | 1,072,340.00 | 5.30 | -1.86 | 7.69 | -2.99 | 83.00 | 83.45 | 6.63 | -2.99 | 2.64 | 2.02 | 1.10 | -- | 6.68 | 3.53 | -13.96 | -- | 11.17 | -- |
Boiron SA | 517.36m | 47.62m | 597.42m | 2.81k | 12.42 | 1.07 | 9.05 | 1.15 | 2.74 | 2.74 | 29.79 | 31.73 | 0.6792 | 1.36 | 6.57 | 184,705.80 | 6.14 | 5.08 | 7.56 | 6.39 | 73.88 | 75.12 | 9.04 | 7.40 | 2.54 | -- | 0.0225 | 48.87 | 17.36 | -2.86 | 56.44 | -10.60 | -19.01 | -7.22 |
Pharming Group N.V. | 229.29m | -9.86m | 606.78m | 415.00 | -- | 2.97 | 120.73 | 2.65 | -0.0162 | -0.0162 | 0.349 | 0.3047 | 0.5521 | 0.5089 | 6.65 | 552,504.80 | -2.37 | 5.26 | -2.81 | 6.63 | 89.72 | 89.41 | -4.30 | 9.26 | 3.33 | -4.00 | 0.4395 | -- | 19.30 | 9.01 | -177.14 | -- | -13.04 | -- |
Gubra A/S | 27.48m | -5.97m | 642.20m | 219.00 | -- | 9.95 | -- | 23.37 | -2.91 | -2.91 | 13.51 | 29.44 | -- | -- | -- | 936,095.90 | -- | -- | -- | -- | 56.06 | -- | -21.72 | -- | -- | -- | 0.1296 | -- | 2.82 | -- | -1,133.04 | -- | -- | -- |
Puretech Health PLC | 10.97m | -43.94m | 663.65m | 111.00 | -- | 1.48 | -- | 60.49 | -0.1336 | -0.1336 | 0.0333 | 1.43 | 0.0155 | -- | 3.63 | 84,951.40 | -5.16 | 5.21 | -5.90 | 6.53 | -- | -- | -333.47 | 265.77 | -- | -34.79 | 0.0479 | 0.00 | -10.18 | 43.86 | 16.85 | -- | 0.046 | -- |
Surgical Science Sweden AB | 76.29m | 20.22m | 665.83m | 260.00 | 32.91 | 1.77 | 26.61 | 8.73 | 4.59 | 4.59 | 17.32 | 85.16 | 0.1888 | 1.87 | 6.15 | 3,395,585.00 | 5.00 | 4.49 | 5.31 | 4.78 | 69.42 | 70.06 | 26.50 | 23.75 | 3.56 | -- | 0.00 | 0.00 | 10.01 | 68.14 | 24.47 | -- | 38.57 | -- |
Formycon AG | 68.64m | -42.24m | 690.38m | 224.00 | -- | 1.47 | -- | 10.06 | -2.80 | -2.80 | 4.41 | 26.65 | 0.079 | 91.54 | 2.24 | 334,839.00 | -4.86 | 3.03 | -5.17 | 3.29 | 35.52 | 31.61 | -61.53 | 10.91 | 1.00 | -- | 0.0202 | 0.00 | 16.07 | 7.86 | 370.82 | -- | 120.72 | -- |
Holder | Shares | % Held |
---|---|---|
Financi�re de l'�chiquier SAas of 31 Mar 2023 | 464.46k | 2.65% |
The Vanguard Group, Inc.as of 05 Apr 2024 | 138.93k | 0.79% |
Dimensional Fund Advisors LPas of 04 Apr 2024 | 83.74k | 0.48% |
SMA Gestion SAas of 30 Jun 2021 | 76.17k | 0.43% |
Sycomore Asset Management SAas of 31 Jan 2024 | 69.77k | 0.40% |
Norges Bank Investment Managementas of 31 Dec 2023 | 47.88k | 0.27% |
HC Capital Advisors GmbHas of 30 Jun 2023 | 38.51k | 0.22% |
Gay-Lussac Gestion SAas of 31 Dec 2022 | 32.50k | 0.19% |
Amplegest SASas of 31 Aug 2023 | 24.91k | 0.14% |
Chaussier Gestion SAas of 28 Mar 2024 | 17.00k | 0.10% |